TSS
SBBP

Two Sigma Securities’s Strongbridge Biopharma plc. SBBP Stock Holding History

Two Sigma Securities’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,511
Closed -$31K – 2092
2021
Q2 		$31K Buy
+10,511
New +$27.8K ﹤0.01% 1433

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Two Sigma Securities's SBBP Position: Q3 2021 in Review

Two Sigma Securities sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2021, closing a stake of 10,511 shares — an estimated $31K sold.

Two Sigma Securities first reported a position in SBBP in Q2 2021 and held it in 1 quarter. The position peaked at $31K in Q2 2021. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2021.

  • Two Sigma Securities reported no remaining Strongbridge Biopharma plc. position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Securities sold 10,511 Strongbridge Biopharma plc. shares in Q3 2021, an estimated $31K.
  • Two Sigma Securities first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 1 quarter.
  • Two Sigma Securities's Strongbridge Biopharma plc. position peaked at $31K in Q2 2021.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2021.

Based on Two Sigma Securities's 13F filing for Q3 2021, filed 15 Nov 2021.